Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

1,213 results

• Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): Complete Statistical AnalysisIndependent statistical analysis of Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 12NCT05907213
• KetoPltAggIndependent statistical analysis of IV Ketorolac on Platelet Function Post-Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03805607).Phase 4Results postedn = 40NCT03805607
• KetPTSDIndependent statistical analysis of Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00749203).Phase 2Results postedn = 41NCT00749203
• KINETICIndependent statistical analysis of Ketamine to Improve Recovery After Cesarean Delivery - Part 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037085).Phase 2Results postedn = 8NCT04037085
• KOMETIndependent statistical analysis of Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 145NCT04924608
• KPL-301 for Subjects With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of KPL-301 for Subjects With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03827018).Phase 2Results postedn = 70NCT03827018
• L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: Complete Statistical AnalysisIndependent statistical analysis of L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733407).Phase 1/2Results postedn = 18NCT01733407
• Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114971).Phase 4Results postedn = 75NCT01114971
• Lamotrigine Bioequivalence: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Bioequivalence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01995825).Phase 4Results postedn = 35NCT01995825
• Lamotrigine Extended-Release In Elderly Patients With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Extended-Release In Elderly Patients With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516139).Phase 3Results postedn = 122NCT00516139
• LAMPIndependent statistical analysis of Learning to Apply Mindfulness to Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04526158).Phase NAResults postedn = 811NCT04526158
• Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: Complete Statistical AnalysisIndependent statistical analysis of Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383708).Phase 3Results postedn = 125NCT00383708
• LANTERNIndependent statistical analysis of Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 128NCT02493517
• Late-Onset Treatment Study Extension Protocol: Complete Statistical AnalysisIndependent statistical analysis of Late-Onset Treatment Study Extension Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455195).Phase 4Results postedn = 81NCT00455195
• LEAPSIndependent statistical analysis of Locomotor Experience Applied Post Stroke Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00243919).Phase 3Results postedn = 408NCT00243919
• Learning Impairments Among Survivors of Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Learning Impairments Among Survivors of Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00576472).Phase 4Results postedn = 469NCT00576472
• LED Therapy for the Treatment of Concussive Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of LED Therapy for the Treatment of Concussive Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02383472).Phase NAResults postedn = 53NCT02383472
• LEMTRADA-ITPIndependent statistical analysis of Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 13NCT03784898
• Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 4Results postedn = 343NCT01229735
• Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03940326).Phase 4Results postedn = 103NCT03940326
• LIBERATE – LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: Complete Statistical AnalysisIndependent statistical analysis of LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03887650).Phase 4Results postedn = 90NCT03887650
• Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment: Complete Statistical AnalysisIndependent statistical analysis of Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00628355).Phase 4Results postedn = 30NCT00628355
• Lifeflight: Fentanyl Versus Morphine: Complete Statistical AnalysisIndependent statistical analysis of Lifeflight: Fentanyl Versus Morphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580489).Phase NAResults postedn = 204NCT00580489
• Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03794908).Phase NAResults postedn = 60NCT03794908
• Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1/2Results postedn = 54NCT02133664
• Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 64NCT03182933
• LittlEarsIndependent statistical analysis of Littlears Auditory Questionnaire: Validation Study in CI Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00785707).Phase NAResults postedn = 31NCT00785707
• Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More Hours: Complete Statistical AnalysisIndependent statistical analysis of Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More Hours: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 50NCT02420951
• LOGRIBMETIndependent statistical analysis of Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 115NCT01896050
• Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 190NCT00419393
• Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: Complete Statistical AnalysisIndependent statistical analysis of Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: primary endpoint results, effect estimate…Phase 3Results postedn = 23NCT01246479
• Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 112NCT01753336
• Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 182NCT00811395
• Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 395NCT00595517
• Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 4Results postedn = 331NCT00472199
• Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 13NCT00633139
• Long-term Open-Label Safety Study to Evaluate EN3409: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-Label Safety Study to Evaluate EN3409: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755546).Phase 3Results postedn = 304NCT01755546
• Long-term Outcomes After Percutaneous Closure of PFO: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcomes After Percutaneous Closure of PFO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05558774).Phase NAResults postedn = 364NCT05558774
• Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 23NCT01369615
• Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 327NCT00311363
• Long-Term Study of Nitisinone to Treat Alkaptonuria: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Nitisinone to Treat Alkaptonuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107783).Phase 2Results postedn = 40NCT00107783
• LOOPAn independent statistical analysis of the LOOP trial of implantable loop recorder monitoring, including trial design, the primary stroke or systemic arterial embolism endpoint, planned time-to-event analysis, and statistical interpretation.Phase NAn = 6,000NCT02036450
• LOVIT IIIndependent statistical analysis of Low Vision Intervention Trial II (LOVIT II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00958360).Phase 2Results postedn = 323NCT00958360
• Low Intensity Ultrasound Therapy for Upper Back Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Low Intensity Ultrasound Therapy for Upper Back Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02135094).Phase NAResults postedn = 33NCT02135094
• M-F0434Independent statistical analysis of Neuropathic Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263132).Phase 3Results postedn = 104NCT01263132
• M032-HSV-1Independent statistical analysis of Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 29NCT02062827
• MADIndependent statistical analysis of Mandibular Advancement Device and Changes in Nocturia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05562388).Phase NAResults postedn = 11NCT05562388
• Magnesium vs Placebo for Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Magnesium vs Placebo for Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218424).Phase 2/3Results postedn = 60NCT02218424
• MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients): Complete Statistical AnalysisIndependent statistical analysis of MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 43NCT04724291
• Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 12NCT01342757

← All therapeutic areas